Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Recommendations

Info

Notes 288
Notes 289
Page 2 and 3:
AIDS Vaccine 2012 PROGRAM AT A GLAN
Page 4 and 5:
AIDS Vaccine 2012 Partners www.alli
Page 6 and 7:
CONFERENCE ORGANIZERS Conference Or
Page 8 and 9:
CONFERENCE ORGANIZERS Conference Or
Page 10 and 11:
SCHOLARSHIP RECIPIENTS Awards and S
Page 12 and 13:
SCHOLARSHIP RECIPIENTS Awards and S
Page 14 and 15:
PROGRAM / MONDAY 2 Program Monday,
Page 16 and 17:
PROGRAM / MONDAY 4 Program 11:00 -
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
PROGRAM / TUESDAY 10 Program Tuesda
Page 24 and 25:
PROGRAM / TUESDAY 12 Program 11:45
Page 26 and 27:
PROGRAM / TUESDAY 14 Program 13:30
Page 28 and 29:
PROGRAM / TUESDAY 16 Program Poster
Page 30 and 31:
PROGRAM / TUESDAY 18 Program AIDS V
Page 32 and 33:
PROGRAM / WEDNESDAY 20 Program Wedn
Page 34 and 35:
22 AIDS Vaccine 2012
Page 36 and 37:
PLENARY SESSIONS 24 Plenary Session
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
SYMPOSIA SESSIONS 30 Symposia Sessi
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
ORAL ABSTRACT SESSIONS 54 Oral Abst
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
92 AIDS Vaccine 2012
Page 106 and 107:
POSTERS 94 AIDS Vaccine 2012
Page 108 and 109:
POSTERS 96 Posters Topic 1: Adjuvan
Page 110 and 111:
POSTERS 98 Posters Topic 1: Adjuvan
Page 112 and 113:
POSTERS Posters Topic 1: Adjuvants,
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
POSTERS Posters Topic 2: Animal Mod
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
POSTERS Posters Topic 3: B Cell Imm
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
POSTERS Posters Topic 4: Clinical V
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
POSTERS Posters Topic 5: HIV Transm
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
POSTERS Posters Topic 6: Immunogene
Page 192 and 193:
POSTERS Posters Topic 7: Innate Imm
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
POSTERS Posters Topic 8: Mucosal Im
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
POSTERS Posters Topic 9: Non-Vaccin
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
POSTERS Posters Topic 10: Social/Et
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
POSTERS Posters Topic 11: T Cell Im
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251: POSTERS Posters Topic 11: T Cell Im
Page 252 and 253: POSTERS Posters Topic 11: T Cell Im
Page 254 and 255: POSTERS Posters Topic 12: Vaccine C
Page 288 and 289: POSTERS Posters Topic 13: Pediatric
Page 290 and 291: AUTHOR INDEX Author Index Brander,
Page 292 and 293: AUTHOR INDEX Author Index Guan, Y .
Page 294 and 295: AUTHOR INDEX Author Index Lucas, J.
Page 296 and 297: AUTHOR INDEX Author Index Quinn, T
Page 298 and 299: AUTHOR INDEX Author Index Wendel-Ha
Page 302 and 303: Notes 290
Page 305: Poster Session 1 - Monday, 10 Septe
show all

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Create successful ePaper yourself

Delete template?

Save as template?